Unibioscreen Overview

  • Founded
  • 1999
  • Status
  • Out of Business
  • Employees
  • 2
  • Latest Deal Type
  • Out of Business

Unibioscreen General Information


Provider of oncology drugs intended for the treatment of cancer. The company's oncology drugs include unique, novel and effective cytotoxic and anti-migratory cancer chemotherapeutics mainly sourced from natural products enables its customers with low toxicity, cytotoxic and anti-migratory drugs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Avenue Joseph Wybran 40
  • 1070 Brussels
  • Belgium
+32 02 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Unibioscreen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Jul-2009 000.00 Completed Out of Business
4. Later Stage VC 01-Mar-2008 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 02-Aug-2002 000.00 000.00 Completed Startup
2. Early Stage VC 01-Apr-2001 $1.81M $2.88M Completed Startup
1. Seed Round 01-Nov-1999 $1.07M $1.07M Completed Startup
To view Unibioscreen’s complete valuation and funding history, request access »

Unibioscreen Executive Team (7)

Name Title Board Seat Contact Info
Francis Darro Co-Founder, Chief Organizing Officer & Managing Director
Steven Weitman Ph.D Chief Marketing Officer
Frank Van Vynckt Chief Production and Manufacture Officer
Yvan De Launoit Co-Founder & Board Member
Dimitri Dimitriou Commercial Advisor & Chief Business Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Unibioscreen Board Members (1)

Name Representing Role Since
Yvan De Launoit Unibioscreen Co-Founder & Board Member 000 0000
To view Unibioscreen’s complete board members history, request access »

Unibioscreen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial